Polysaccharide biological response modifiers

Immunology Letters

Volumn 105, Issue 2, 2006, Pages 101-114

  Leung, M Y K ^a   Liu, C ^a   Koon, J C M ^a   Fung, K P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biological response modifier; Fucoidan; Glucan; Mannan; Pattern recognition receptor; Pectin; Polysaccharide

Indexed keywords

BACTERIAL POLYSACCHARIDE; BETA 1,3 GLUCAN; BETA GLUCAN; BIOLOGICAL RESPONSE MODIFIER; CHITIN; CHITOSAN; CURDLAN; EXOPOLYSACCHARIDE; FUCOIDIN; MANNAN; PECTIN; POLYSACCHARIDE; SCHIZOPHYLLAN; SUCCINOGLYCAN;

ABSENCE OF SIDE EFFECTS; ALCALIGENES FAECALIS; ALOE VERA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ASCOMYCETES; BACTERIAL STRAIN; BASIDIOMYCETES; BIOLOGICAL ACTIVITY; BREAST CANCER; BROWN ALGA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL WALL; CHEMICAL PROCEDURES; CLINICAL TRIAL; COLORECTAL CANCER; DEUTEROMYCETES; DIGESTIVE SYSTEM CANCER; DRUG ACTIVITY; FUNGAL STRAIN; GLUCONACETOBACTER XYLINUS; HUMAN; IMMUNE RESPONSE; LUNG CANCER; MOLECULAR RECOGNITION; NONHUMAN; PHOTOSYNTHESIS; PLANT CELL; PRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PURIFICATION; QUALITY OF LIFE; REVIEW; RHIZOBIUM; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX CANCER; YEAST; ZYGOMYCETES;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; LIGANDS; POLYSACCHARIDES; RECEPTORS, IMMUNOLOGIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33744533045     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.01.009     Document Type: Review

References (224)

1. Soell M., Diab M., Haan-Archipoff G., Beretz A., Herbelin C., Poutrel B., et al. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun 63 (1995) 1380-1386
2. Choy Y.M., Tsang S.F., Kong S.K., Leung K.N., Parolis H., Lee C.Y., et al. K1 and K3 capsular antigens of Klebsiella induce tumor necrosis factor activities. Life Sci 58 (1996) PL153-PL158
3. Kwok T.T., Chen P., Liu P.Y., Tang Y.C., Kong S.K., Fung K.P., et al. The anti-tumour effect of Klebsiella pneumoniae capsular polysaccharides. Biol Signal Recept 10 (2001) 294-298
4. Tzianabos A., Wang J.Y., and Kasper D.L. Biological chemistry of immunomodulation by zwitterionic polysaccharides. Carbohydr Res 338 (2003) 2531-2538
5. Daley L., Pier G.B., Liporace J.D., and Eardley D.D. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J Immunol 134 (1985) 3089-3093
6. Perez-Fernandez M.E., Quesada E., Galvez J., and Ruiz C. Effect of exopolysaccharide V2-7, isolated from Halomonas eurihalina, on the proliferation in vitro of human peripheral blood lymphocytes. Immunopharmacol Immunotoxicol 22 (2000) 131-141
7. Ruiz-Bravo A., Jimenez-Valera M., Moreno E., Guerra V., and Ramos-Cormenzana A. Biological response modifier activity of an exopolysaccharide from Paenibacillus jamilae CP-7. Clin Diagn Lab Immunol 8 (2001) 706-710
8. Li W., Yajima T., Saito K., Nishimura H., Fushimi T., Ohshima Y., et al. Immunostimulating properties of intragastrically administered Acetobacter-derived soluble branched (1,4)-β-d-glucans decrease murine susceptibility to Listeria monocytogenes. Infect Immun 72 (2004) 7005-7011
9. Schleifer K.H., and Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36 (1972) 407-477
10. Costerton J.W., Irvin R.T., and Cheng K.J. The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 35 (1981) 299-324
11. Moxon E.R., and Kroll J.S. The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol 150 (1990) 65-85
12. Roberts I.S. Bacterial polysaccharides in sickness and in health. The 1995 Fleming lecture. Microbiology 141 (1995) 2023-2031
13. Whitfield C., and Valvano M.A. Biosynthesis and expression of cell-surface polysaccharides in gram-negative bacteria. Adv Microb Physiol 35 (1993) 135-246
14. Kogan G., Jann B., and Jann K. Structure of the Escherichia coli 0104 polysaccharide and its identity with the capsular K9 polysaccharide. FEMS Microbiol Lett 70 (1992) 135-140
15. Orskov I., Sharma V., and Orskov F. Genetic mapping of the K1 and K4 antigens (L) of Escherichia coli. Non-allelism of K(L) antigens with K antigens of O8:K27(A), O8:K8(L) and O9:K57(B). Acta Pathol Microbiol Scand B 84 (1976) 125-131
16. Orskov F., and Orskov I. Escherichia coli serotyping and disease in man and animals. Can J Microbiol 38 (1992) 699-704
17. van Dam J.E., Fleer A., and Snippe H. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Van Leeuwenhoek 58 (1990) 1-47
18. Robbins J.B., McCracken Jr. G.H., Gotschlich E.C., Orskov F., Orskov I., and Hanson L.A. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med 290 (1974) 1216-1220
19. Rodriguez-Carvajal M.A., Rodrigues J.A., Soria-Diaz M.E., Tejero-Mateo P., Buendia-Claveria A., Gutierrez R., et al. Structural analysis of the capsular polysaccharide from Sinorhizobium fredii HWG35. Biomacromolecules 6 (2005) 1448-1456
20. Moreau M., Richards J.C., Fournier J.M., Byrd R.A., Karakawa W.W., and Vann W.F. Structure of the type 5 capsular polysaccharide of Staphylococcus aureus. Carbohydr Res 201 (1990) 285-297
21. Beynon L.M., Richards J.C., and Perry M.B. Structure of the capsular polysaccharide from Actinobacillus pleuropneumoniae serotype 10. Carbohydr Res 220 (1991) 185-193
22. Altman E., Brisson J.R., Gagne S.M., and Perry M.B. Structure of the capsular polysaccharide of Actinobacillus pleuropneumoniae serotype 5b. Eur J Biochem 204 (1992) 225-230
23. Reddy G.P., Hayat U., Abeygunawardana C., Fox C., Wright A.C., Maneval Jr. D.R., et al. Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol 174 (1992) 2620-2630
24. Reddy G.P., Hayat U., Bush C.A., and Morris Jr. J.G. Capsular polysaccharide structure of a clinical isolate of Vibrio vulnificus strain BO62316 determined by heteronuclear NMR spectroscopy and high-performance anion-exchange chromatography. Anal Biochem 214 (1993) 106-115
25. Nath R.K., and Chakraborty A.K. Structural studies on the capsular polysaccharide of Klebsiella serotype K40. Eur J Biochem 162 (1987) 439-443
26. Joseleau J.P., and Marais M.F. The structural repeating-unit of the capsular polysaccharide from Klebsiella serotype K48. Carbohydr Res 179 (1988) 321-326
27. Parolis H., Parolis L.A., Stanley S.M., and Dutton G.G. The structure of the capsular antigen from Escherichia coli O8:K87:H19. Carbohydr Res 205 (1990) 361-370
28. de Bruin A.H., Parolis H., and Parolis L.A. The capsular antigen of Escherichia coli serotype O8:K102:H. Carbohydr Res 235 (1992) 199-209
29. Edebrink P., Jansson P.E., Widmalm G., and Nimmich W. The structure of the capsular polysaccharide from Klebsiella K43. Carbohydr Res 257 (1994) 107-115
30. Beynon L.M., Richards J.C., and Perry M.B. Identification of the common antigenic determinant shared by Streptococcus pneumoniae serotypes 35A and 20 capsular polysaccharides-structural analysis of the Streptococcus pneumoniae serotype 35A capsular polysaccharide. Eur J Biochem 250 (1997) 163-167
31. Kasper D.L., Weintraub A., Lindberg A.A., and Lonngren J. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol 153 (1983) 991-997
32. Knirel Y.A., Paredes L., Jansson P.E., Weintraub A., Widmalm G., and Albert M.J. Structure of the capsular polysaccharide of Vibrio cholerae O139 synonym Bengal containing d-galactose 4,6-cyclophosphate. Eur J Biochem 232 (1995) 391-396
33. Sheng S., and Cherniak R. Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 10 determined by NMR spectroscopy. Carbohydr Res 305 (1997) 65-72
34. Zubkov V.A., Nazarenko E.L., Gorshkova R.P., Ivanova E.P., Shashkov A.S., Knirel Y.A., et al. Structure of the capsular polysaccharide from Alteromonas sp. CMM 155. Carbohydr Res 275 (1995) 147-154
35. Volpi N. Purification of the Escherichia coli K5 capsular polysaccharide and use of high-performance capillary electrophoresis to qualitative and quantitative monitor the process. Electrophoresis 25 (2004) 3307-3312
36. Harada T. Special bacterial polysaccharides and polysaccharases. Biochem Soc Symp 48 (1983) 97-116
37. Kenyon W.J., Esch S.W., and Buller C.S. The curdlan-type exopolysaccharide produced by Cellulomonas flavigena KU forms part of an extracellular glycocalyx involved in cellulose degradation. Antonie Van Leeuwenhoek 87 (2005) 143-148
38. Annison G., and Couperwhite I. Composition of alginate synthesized during the growth cycle of Pseudomonas aeruginosa. Aust J Biol Sci 40 (1987) 435-441
39. Orgambide G., Montrozier H., Servin P., Roussel J., Trigalet-Demery D., and Trigalet A. High heterogeneity of the exopolysaccharides of Pseudomonas solanacearum strain GMI 1000 and the complete structure of the major polysaccharide. J Biol Chem 266 (1991) 8312-8321
40. Bartnicki-Garcia S. Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 22 (1968) 87-108
41. Kitajma Y. Structural and biochemical characteristics of pathogenic fungus: cell walls, lipids and dimorphism, and action modes of antifungal agents. Nippon Ishinkin Gakkai Zasshi 41 (2000) 211-217
42. Wessels J.G., Kreger D.R., Marchant R., Regensburg B.A., and De Vries O.M. Chemical and morphological characterization of the hyphal wall surface of the basidiomycete Schizophyllum commune. Biochim Biophys Acta 273 (1972) 346-358
43. Cabib E., Bowers B., Sburlati A., and Silverman S.J. Fungal cell wall synthesis: the construction of a biological structure. Microbiol Sci 5 (1988) 370-375
44. Aguilar-Uscanga B., and Francois J.M. A study of the yeast cell wall composition and structure in response to growth conditions and mode of cultivation. Lett Appl Microbiol 37 (2003) 268-274
45. Williams D.L., McNamee R.B., Jones E.L., Pretus H.A., Ensley H.E., Browder I.W., et al. A method for the solubilization of a (1 → 3)-β-d-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 219 (1991) 203-213
46. Stokke B.T., Elgsaeter A., Hara C., Kitamura S., and Takeo K. Physicochemical properties of (1 → 6)-branched (1 → 3)-β-d-glucans. 1. Physical dimensions estimated from hydrodynamic and electron microscopic data. Biopolymers 33 (1993) 561-573
47. Krainer E., Stark R.E., Naider F., Alagramam K., and Becker J.M. Direct observation of cell wall glucans in whole cells of Saccharomyces cerevisiae by magic-angle spinning 13C-NMR. Biopolymers 34 (1994) 1627-1635
48. Kopecka M., Phaff H.J., and Fleet G.H. Demonstration of a fibrillar component in the cell wall of the yeast Saccharomyces cerevisiae and its chemical nature. J Cell Biol 62 (1974) 66-76
49. Manners D.J., and Masson A.J. The structures of two glucans from yeast-cell walls. FEBS Lett 4 (1969) 122-124
50. Manners D.J., Masson A.J., and Patterson J.C. The structure of a β-(1 → 3)-d-glucan from yeast cell walls. Biochem J 135 (1973) 19-30
51. Manners D.J., Masson A.J., and Patterson J.C. The heterogeneity of glucan preparations from the walls of various yeasts. J Gen Microbiol 80 (1974) 411-417
52. Kollar R., Petrakova E., Ashwell G., Robbins P.W., and Cabib E. Architecture of the yeast cell wall. The linkage between chitin and β(1 → 3)-glucan. J Biol Chem 270 (1995) 1170-1178
53. Frevert J., and Ballou C.E. Saccharomyces cerevisiae structural cell wall mannoprotein. Biochemistry 24 (1985) 753-759
54. Kollar R., Reinhold B.B., Petrakova E., Yeh H.J., Ashwell G., Drgonova J., et al. Architecture of the yeast cell wall. β(1 → 6)-Glucan interconnects mannoprotein, β(1 → 3)-glucan, and chitin. J Biol Chem 272 (1997) 17762-17775
55. Klis F.M., Caro L.H., Vossen J.H., Kapteyn J.C., Ram A.F., Montijn R.C., et al. Identification and characterization of a major building block in the cell wall of Saccharomyces cerevisiae. Biochem Soc Trans 25 (1997) 856-860
56. Brawley S.H., Quatrano R.S., and Wetherbee R. Fine-structural studies of the gametes and embryo of Fucus vesiculosus L. (Phaeophyta). I. Fertilization and pronuclear fusion. J Cell Sci 20 (1976) 233-254
57. Zeller S.G., and Gray G.R. Analysis of Macrocystis pyrifera and Pseudomonas aeruginosa alginic acids by the reductive-cleavage method. Carbohydr Res 226 (1992) 313-326
58. Klock G., Pfeffermann A., Ryser C., Grohn P., Kuttler B., Hahn H.J., et al. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18 (1997) 707-713
59. Tako M., Kiyuna S., Uechi S., and Hongo F. Isolation and characterization of alginic acid from commercially cultured Nemacystus decipiens (Itomozuku). Biosci Biotechnol Biochem 65 (2001) 654-657
60. Aspinall G.O., and Monteiro M.A. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry 35 (1996) 2498-2504
61. Patankar M.S., Oehninger S., Barnett T., Williams R.L., and Clark G.F. A revised structure for fucoidan may explain some of its biological activities. J Biol Chem 268 (1993) 21770-21776
62. Chevolot L., Foucault A., Chaubet F., Kervarec N., Sinquin C., Fisher A.M., et al. Further data on the structure of brown seaweed fucans: relationships with anticoagulant activity. Carbohydr Res 319 (1999) 154-165
63. Chevolot L., Mulloy B., Ratiskol J., Foucault A., and Colliec-Jouault S. A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr Res 330 (2001) 529-535
64. Daniel R., Berteau O., Chevolot L., Varenne A., Gareil P., and Goasdoue N. Regioselective desulfation of sulfated l-fucopyranoside by a new sulfoesterase from the marine mollusk Pecten maximus: application to the structural study of algal fucoidan (Ascophyllum nodosum). Eur J Biochem 268 (2001) 5617-5626
65. Chizhov A.O., Dell A., Morris H.R., Haslam S.M., McDowell R.A., Shashkov A.S., et al. A study of fucoidan from the brown seaweed Chorda filum. Carbohydr Res 320 (1999) 108-119
66. Nagaoka M., Shibata H., Kimura-Takagi I., Hashimoto S., Kimura K., Makino T., et al. Structural study of fucoidan from Cladosiphon okamuranus TOKIDA. Glycoconj J 16 (1999) 19-26
67. Nishino T., Nishioka C., Ura H., and Nagumo T. Isolation and partial characterization of a novel amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan. Carbohydr Res 255 (1994) 213-224
68. Ponce N.M., Pujol C.A., Damonte E.B., Flores M.L., and Stortz C.A. Fucoidans from the brown seaweed Adenocystis utricularis: extraction methods, antiviral activity and structural studies. Carbohydr Res 338 (2003) 153-165
69. Ni Y., Turner D., Yates K.M., and Tizard I. Isolation and characterization of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol 4 (2004) 1745-1755
70. Mueller E.A., and Anderer F.A. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition. Cancer Res 50 (1990) 3646-3651
71. Yamada H., Komiyama K., Kiyohara H., Cyong J.C., Hirakawa Y., and Otsuka Y. Structural characterization and antitumor activity of a pectic polysaccharide from the roots of Angelica acutiloba. Planta Med 56 (1990) 182-186
72. Sepehri H., Roghani M., and Houdebine M.L. Oral administration of pectin-rich plant extract enhances C3 and C4 complement concentration in woman colostrum. Reprod Nutr Dev 38 (1998) 255-260
73. Hayashi A., Gillen A.C., and Lott J.R. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice. Altern Med Rev 5 (2000) 546-552
74. Saima Y., Das A.K., Sarkar K.K., Sen A.K., and Sur P. An antitumor pectic polysaccharide from Feronia limonia. Int J Biol Macromol 27 (2000) 333-335
75. Diallo D., Paulsen B.S., Liljeback T.H., and Michaelsen T.E. The malian medicinal plant Trichilia emetica; studies on polysaccharides with complement fixing ability. J Ethnopharmacol 84 (2003) 279-287
76. Capek P., and Hribalova V. Water-soluble polysaccharides from Salvia officinalis L. possessing immunomodulatory activity. Phytochemistry 65 (2004) 1983-1992
77. Hokputsa S., Harding S.E., Inngjerdingen K., Jumel K., Michaelsen T.E., Heinze T., et al. Bioactive polysaccharides from the stems of the Thai medicinal plant Acanthus ebracteatus: their chemical and physical features. Carbohydr Res 339 (2004) 753-762
78. Willats W.G., McCartney L., Mackie W., and Knox J.P. Pectin: cell biology and prospects for functional analysis. Plant Mol Biol 47 (2001) 9-27
79. Cosgrove D.J. Assembly and enlargement of the primary cell wall in plants. Annu Rev Cell Dev Biol 13 (1997) 171-201
80. Matsunaga T., Ishii T., Matsumoto S., Higuchi M., Darvill A., Albersheim P., et al. Occurrence of the primary cell wall polysaccharide rhamnogalacturonan II in pteridophytes, lycophytes, and bryophytes. Implications for the evolution of vascular plants. Plant Physiol 134 (2004) 339-351
81. O'Neill M.A., Ishii T., Albersheim P., and Darvill A.G. Rhamnogalacturonan II: structure and function of a borate cross-linked cell wall pectic polysaccharide. Annu Rev Plant Biol 55 (2004) 109-139
82. Whitcombe A.J., O'Neill M.A., Steffan W., Albersheim P., and Darvill A.G. Structural characterization of the pectic polysaccharide, rhamnogalacturonan-II. Carbohydr Res 271 (1995) 15-29
83. Domenico P., Diedrich D.L., and Straus D.C. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. Can J Microbiol 31 (1985) 472-478
84. Inzana T.J. Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect Immun 55 (1987) 1573-1579
85. Cherniak R., and Frederick H.M. Capsular polysaccharide of Clostridium perfringens Hobbs 9. Infect Immun 15 (1977) 765-771
86. Gorshkova R.P., Nazarenko E.L., Zubkov V.A., Shashkov A.S., Knirel Y.A., Paramonov N.A., et al. Structure of the capsular polysaccharide from Alteromonas nigrifaciens IAM 13010T containing 2-acetamido-2,6-dideoxy-l-talose and 3-deoxy-d-manno-octulosonic acid. Carbohydr Res 299 (1997) 69-76
87. Zevenhuizen L.P., and Scholten-Koerselman H.J. Surface carbohydrates of Rhizobium. I. β-1,2-Glucans. Antonie Van Leeuwenhoek 45 (1979) 165-175
88. Carrion M., Bhat U.R., Reuhs B., and Carlson R.W. Isolation and characterization of the lipopolysaccharides from Bradyrhizobium japonicum. J Bacteriol 172 (1990) 1725-1731
89. Hashimoto M., Kirikae F., Dohi T., Kusumoto S., Suda Y., and Kirikae T. Structural elucidation of a capsular polysaccharide from a clinical isolate of Bacteroides vulgatus from a patient with Crohn's disease. Eur J Biochem 268 (2001) 3139-3144
90. Blaschek W., Kasbauer J., Kraus J., and Franz G. Pythium aphanidermatum: culture, cell-wall composition, and isolation and structure of antitumour storage and solubilised cell-wall (1 → 3), (1 → 6)-β-d-glucans. Carbohydr Res 231 (1992) 293-307
91. Leung M.Y., Fung K.P., and Choy Y.M. The isolation and characterization of an immunomodulatory and anti-tumor polysaccharide preparation from Flammulina velutipes. Immunopharmacology 35 (1997) 255-263
92. Ohno N., Furukawa M., Miura N.N., Adachi Y., Motoi M., and Yadomae T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull 24 (2001) 820-828
93. Yalin W., Ishurd O., Cuirong S., and Yuanjiang P. Structure analysis and antitumor activity of (1 → 3)-β-d-glucans (cordyglucans) from the mycelia of Cordyceps sinensis. Planta Med 71 (2005) 381-384
94. Leung M.Y., Liu C., Zhu L.F., Hui Y.Z., Yu B., and Fung K.P. Chemical and biological characterization of a polysaccharide biological response modifier from Aloe vera L. var. chinensis (Haw.). Berg Glycobiol 14 (2004) 501-510
95. Kohno M., Abe S., Sato K., Yamazaki M., and Mizuno D. Antitumor activity of polysaccharide TC-13 extracted from rare actinomycetes. Jpn J Exp Med 53 (1983) 1-9
96. Kim G.Y., Park H.S., Nam B.H., Lee S.J., and Lee J.D. Purification and characterization of acidic proteo-heteroglycan from the fruiting body of Phellinus linteus (Berk. & M. A. Curtis) Teng. Bioresour Technol 89 (2003) 81-87
97. Kim G.Y., Choi G.S., Lee S.H., and Park Y.M. Acidic polysaccharide isolated from Phellinus linteus enhances through the up-regulation of nitric oxide and tumor necrosis factor-α from peritoneal macrophages. J Ethnopharmacol 95 (2004) 69-76
98. Kitamura S., and Kuge T. A differential scanning calorimetric study of the conformational transitions of schizophyllan in mixtures of water and dimethylsulfoxide. Biopolymers 28 (1989) 639-654
99. Falch B.H., Elgsaeter A., and Stokke B.T. Exploring the (1 → 3)-β-d-glucan conformational phase diagrams to optimize the linear to macrocycle conversion of the triple-helical polysaccharide scleroglucan. Biopolymers 50 (1999) 496-512
100. Yadomae T. Structure and biological activities of fungal β-1,3-glucans. Yakugaku Zasshi 120 (2000) 413-431
101. Zhang X., Zhang L., and Xu X. Morphologies and conformation transition of lentinan in aqueous NaOH solution. Biopolymers 75 (2004) 187-195
102. Zhang L., Li X., Xu X., and Zeng F. Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydr Res 34 (2005) 1515-1521
103. Wang Y., Zhang L., Li Y., Hou X., and Zeng F. Correlation of structure to antitumor activities of five derivatives of a β-glucan from Poria cocos sclerotium. Carbohydr Res 339 (2004) 2567-2574
104. Grimmecke H.D., Meyer H., Scheller D., and Reuter G. Structure of the cell wall polysaccharide in the food protein yeast Candida spec H. III. Characterization of different phosphate bonds in the mannan-protein-phosphate complex. Z Allg Mikrobiol 21 (1981) 201-210
105. Saxena A., Hammer C.F., and Cihlar R.L. Analysis of mannans of two relatively avirulent mutant strains of Candida albicans. Infect Immun 57 (1989) 413-419
106. Funayama M., Nishikawa A., Shinoda T., and Fukazawa Y. Immunochemical determinant of Candida parapsilosis. Carbohydr Res 117 (1983) 229-239
107. Fleet G.H., and Manners D.J. Isolation and composition of an alkali-soluble glucan from the cell walls of Saccharomyces cerevisiae. J Gen Microbiol 94 (1976) 180-192
108. Nguyen T.H., Fleet G.H., and Rogers P.L. Composition of the cell walls of several yeast species. Appl Microbiol Biotechnol 50 (1998) 206-212
109. Lee J.N., Lee D.Y., Ji I.H., Kim G.E., Kim H.N., Sohn J., et al. Purification of soluble β-glucan with immune-enhancing activity from the cell wall of yeast. Biosci Biotechnol Biochem 65 (2001) 837-841
110. Muller A., Ensley H., Pretus H., McNamee R., Jones E., McLaughlin E., et al. The application of various protic acids in the extraction of (1 → 3)-β-d-glucan from Saccharomyces cerevisiae. Carbohydr Res 299 (1997) 203-208
111. Miura N.N., Adachi Y., Yadomae T., Tamura H., Tanaka S., and Ohno N. Structure and biological activities of β-glucans from yeast and mycelial forms of Candida albicans. Microbiol Immunol 47 (2003) 173-182
112. Ohno N., Uchiyama M., Tsuzuki A., Tokunaka K., Miura N.N., Adachi Y., et al. Solubilization of yeast cell-wall β-(1 → 3)-d-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr Res 316 (1999) 161-172
113. Bilang M., Attioui F., Loppinet V., Michalski J.C., and Bonaly R. Structure of the phosphopeptidomannans from flocculent and non-flocculent yeast Kluyveromyces lactis. Carbohydr Res 280 (1996) 303-313
114. El-Hage N., Wu G., Wang J., Ambati J., Knapp P.E., Reed J.L., et al. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia (2005)
115. Beress A., Wassermann O., Tahhan S., Bruhn T., Beress L., Kraiselburd E.N., et al. A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus. J Nat Prod 56 (1993) 478-488
116. Fujimura T., Shibuya Y., Moriwaki S., Tsukahara K., Kitahara T., Sano T., et al. Fucoidan is the active component of Fucus vesiculosus that promotes contraction of fibroblast-populated collagen gels. Biol Pharm Bull 23 (2000) 1180-1184
117. Preeprame S., Hayashi K., Lee J.B., Sankawa U., and Hayashi T. A novel antivirally active fucan sulfate derived from an edible brown alga, Sargassum horneri. Chem Pharm Bull (Tokyo) 49 (2001) 484-485
118. Zhuang C., Itoh H., Mizuno T., and Ito H. Antitumor active fucoidan from the brown seaweed, umitoranoo (Sargassum thunbergii). Biosci Biotechnol Biochem 59 (1995) 563-567
119. Yagi A., Hamada K., Mihashi K., Harada N., and Nishioka I. Structure determination of polysaccharides in Aloe saponaria (Hill.) Haw. (Liliaceae). J Pharm Sci 73 (1984) 62-65
120. Vilkas E., and Radjabi-Nassab F. The glucomannan system from Aloe vahombe (liliaceae). III. Comparative studies on the glucomannan components isolated from the leaves. Biochimie 68 (1986) 1123-1127
121. Sakagami H., Ikeda M., Unten S., Takeda K., Murayama J., Hamada A., et al. Antitumor activity of polysaccharide fractions from pine cone extract of Pinus parviflora Sieb. et Zucc. Anticancer Res 7 (1987) 1153-1159
122. Zhang Y., Kiyohara H., Matsumoto T., and Yamada H. Fractionation and chemical properties of immunomodulating polysaccharides from roots of Dipsacus asperoides. Planta Med 63 (1997) 393-399
123. Xu H.X., Lee S.H., Lee S.F., White R.L., and Blay J. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res 44 (1999) 43-54
124. Chun H., Shin D.H., Hong B.S., Cho H.Y., and Yang H.C. Purification and biological activity of acidic polysaccharide from leaves of Thymus vulgaris L. Biol Pharm Bull 24 (2001) 941-946
125. Nergard C.S., Matsumoto T., Inngjerdingen M., Inngjerdingen K., Hokputsa S., Harding S.E., et al. Structural and immunological studies of a pectin and a pectic arabinogalactan from Vernonia kotschyana Sch. Bip. ex Walp. (Asteraceae). Carbohydr Res 340 (2005) 115-130
126. Ishii T., and Matsunaga T. Pectic polysaccharide rhamnogalacturonan II is covalently linked to homogalacturonan. Phytochemistry 57 6 (2001) 969-974
127. Bao X., Wang Z., Fang J., and Li X. Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis. Planta Med 68 (2002) 237-243
128. Kwon K.H., Kim K.I., Jun W.J., Shin D.H., Cho H.Y., and Hong B.S. In vitro and in vivo effects of macrophage-stimulatory polysaccharide from leaves of Perilla frutescens var. crispa. Biol Pharm Bull 25 (2002) 367-371
129. Kim Y.S., Ryu J.H., Han S.J., Choi K.H., Nam K.B., Jang I.H., et al. Gram-negative bacteria-binding protein, a pattern recognition receptor for lipopolysaccharide and, β-1,3-glucan that mediates the signaling for the induction of innate immune genes in Drosophila melanogaster cells. J Biol Chem 275 (2000) 32721-32727
130. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
131. Means T.K., Golenbock D.T., and Fenton M.J. Structure and function of Toll-like receptor proteins. Life Sci 68 (2000) 241-258
132. Schuster J.M., and Nelson P.S. Toll receptors: an expanding role in our understanding of human disease. J Leukoc Biol 67 (2000) 767-773
133. Akira S., and Takeda K. Functions of Toll-like receptors: lessons from KO mice. C R Biol 327 (2004) 581-589
134. Gough P.J., and Gordon S. The role of scavenger receptors in the innate immune system. Microb Infect 2 (2000) 305-311
135. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M., and Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem 268 (1993) 4569-4572
136. Brown M.S., and Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52 (1983) 223-261
137. Krieger M., and Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63 (1994) 601-637
138. Kim W.S., Ordija C.M., and Freeman M.W. Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A. Biochem Biophys Res Commun 310 (2003) 542-549
139. Czop J.K., and Austen K.F. A β-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol 134 (1985) 2588-2593
140. Czop J.K., and Kay J. Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J Exp Med 173 (1991) 1511-1520
141. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., et al. Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med 196 (2002) 407-412
142. Zamze S., Martinez-Pomares L., Jones H., Taylor P.R., Stillion R.J., Gordon S., et al. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor. J Biol Chem 277 (2002) 41613-41623
143. Ross G.D., and Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 92 (1993) 181-184
144. Fujita T., Matsushita M., and Endo Y. The lectin-complement pathway-its role in innate immunity and evolution. Immunol Rev 198 (2004) 185-202
145. Kilpatrick D.C. Mannan-binding lectin and its role in innate immunity. Transfus Med 12 (2002) 335-352
146. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
147. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., and Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197 (2003) 1119-1124
148. Peiser L., Mukhopadhyay S., and Gordon S. Scavenger receptors in innate immunity. Curr Opin Immunol 14 (2002) 123-128
149. Willment J.A., Marshall A.S., Reid D.M., Williams D.L., Wong S.Y., Gordon S., et al. The human β-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 35 (2005) 1539-1547
150. Shepherd V.L., Tarnowski B.I., and McLaughlin B.J. Isolation and characterization of a mannose receptor from human pigment epithelium. Invest Ophthalmol Vis Sci 32 (1991) 1779-1784
151. Lew D.B., Songu-Mize E., Pontow S.E., Stahl P.D., and Rattazzi M.C. A mannose receptor mediates mannosyl-rich glycoprotein-induced mitogenesis in bovine airway smooth muscle cells. J Clin Invest 94 (1994) 1855-1863
152. Linehan S.A., Martinez-Pomares L., Stahl P.D., and Gordon S. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J Exp Med 189 (1999) 1961-1972
153. Nagi N., Ohno N., Adachi Y., Aketagawa J., Tamura H., Shibata Y., et al. Application of limulus test (G pathway) for the detection of different conformers of (1 → 3)-β-d-glucans. Biol Pharm Bull 16 (1993) 822-828
154. Abel G., Szollosi J., Chihara G., and Fachet J. Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. Int J Immunopharmacol 11 (1989) 615-621
155. Sakurai T., Ohno N., Suzuki I., and Yadomae T. Effect of soluble fungal (1 → 3)-β-d-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation. Immunopharmacology 30 (1995) 157-166
156. Zhang L., and Tizard I.R. Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel. Immunopharmacology 35 (1996) 119-128
157. Estrada A., Yun C.H., Van Kessel A., Li B., Hauta S., and Laarveld B. Immunomodulatory activities of oat β-glucan in vitro and in vivo. Microbiol Immunol 41 (1997) 991-998
158. Stuart R.W., Lefkowitz D.L., Lincoln J.A., Howard K., Gelderman M.P., and Lefkowitz S.S. Upregulation of phagocytosis and candidicidal activity of macrophages exposed to the immunostimulant acemannan. Int J Immunopharmacol 19 (1997) 75-82
159. Djeraba A., and Quere P. In vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera. Int J Immunopharmacol 22 (2000) 365-372
160. Lee J.K., Lee M.K., Yun Y.P., Kim Y., Kim J.S., Kim Y.S., et al. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol 1 (2001) 1275-1284
161. Saito K., Yajima T., Nishimura H., Aiba K., Ishimitsu R., Matsuguchi T., et al. Soluble branched β-(1,4)glucans from Acetobacter species show strong activities to induce interleukin-12 in vitro and inhibit T-helper 2 cellular response with immunoglobulin E production in vivo. J Biol Chem 278 (2003) 38571-38578
162. Shin J.Y., Song J.Y., Yun Y.S., Yang H.O., Rhee D.K., and Pyo S. Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol 24 (2002) 469-482
163. Lim T.S., Na K., Choi E.M., Chung J.Y., and Hwang J.K. Immunomodulating activities of polysaccharides isolated from Panax ginseng. J Med Food 7 (2004) 1-6
164. Vetvicka V., and Yvin J.C. Effects of marine β-1,3 glucan on immune reactions. Int Immunopharmacol 4 (2004) 721-730
165. Kodama N., Murata Y., and Nanba H. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. J Med Food 7 (2004) 141-145
166. Ross G.D., Cain J.A., Myones B.L., Newman S.L., and Lachmann P.J. Specificity of membrane complement receptor type three (CR3) for β-glucans. Complement 4 (1987) 61-74
167. Ezekowitz R.A., Sim R.B., Hill M., and Gordon S. Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med 159 (1984) 244-260
168. Matsumoto T., and Yamada H. Regulation of immune complexes binding of macrophages by pectic polysaccharide from Bupleurum falcatum L.: pharmacological evidence for the requirement of intracellular calcium/calmodulin on Fc receptor up-regulation by bupleuran 2IIb. J Pharm Pharmacol 47 (1995) 152-156
169. Hunter Jr. K.W., DuPre S., and Redelman D. Microparticulate β-glucan upregulates the expression of B7.1, B7.2, B7-H1, but not B7-DC on cultured murine peritoneal macrophages. Immunol Lett 93 (2004) 71-78
170. Okada M., and Minamishima Y. The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice. Microbiol Immunol 31 (1987) 45-57
171. Black P.L., McKinnon K.M., Wooden S.L., and Ussery M.A. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT. Int J Immunopharmacol 18 (1996) 633-650
172. Womble D., and Helderman J.H. The impact of acemannan on the generation and function of cytotoxic T-lymphocytes. Immunopharmacol Immunotoxicol 14 (1992) 63-77
173. Han S.B., Yoon Y.D., Ahn H.J., Lee H.S., Lee C.W., Yoon W.K., et al. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Int Immunopharmacol 3 (2003) 1301-1312
174. Garcia-Lora A., Martinez M., Pedrinaci S., and Garrido F. Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunol Immunother 52 (2003) 59-64
175. Hwang J.S., Chung H.K., Bae E.K., Lee A.Y., Ji H.J., Park D.W., et al. The polysaccharide fraction AIP1 from Artemisia iwayomogi suppresses apoptotic death of the mouse spleen cells in culture. Arch Pharm Res 26 (2003) 294-300
176. Glovsky M.M., Cortes-Haendchen L., Ghekiere L., Alenty A., Williams D.L., and Di Luzio R. Effects of particulate β-1,3 glucan on human, rat, and guinea pig complement activity. J Reticuloendothel Soc 33 (1983) 401-413
177. Honda S., Sugino H., Asano T., and Kakinuma A. Activation of the alternative pathway of complement by an antitumor (1 → 3)-β-d-glucan from Alcaligenes faecalis var. myxogenes IFO, 13140 and its lower molecular weight and carboxymethylated derivatives. Immunopharmacology 11 (1986) 29-37
178. Michaelsen T.E., Gilje A., Samuelsen A.B., Hogasen K., and Paulsen B.S. Interaction between human complement and a pectin type polysaccharide fraction, PMII, from the leaves of Plantago major L. Scand J Immunol 52 (2000) 483-490
179. Suzuki T., Ohno N., Adachi Y., Cirelli A.F., Covian J.A., and Yadomae T. Preparation and biological activities of sulfated derivatives of (1 → 3)-β-d-glucans. J Pharmacobiodyn 14 (1991) 256-266
180. Kurachi K., Ohno N., and Yadomae T. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1 → 3)-β-d-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395. Chem Pharm Bull (Tokyo) 38 (1990) 2527-2531
181. Okazaki M., Adachi Y., Ohno N., and Yadomae T. Structure-activity relationship of (1 → 3)-β-d-glucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull 18 (1995) 1320-1327
182. Falch B.H., Espevik T., Ryan L., and Stokke B.T. The cytokine stimulating activity of (1 → 3)-β-d-glucans is dependent on the triple helix conformation. Carbohydr Res 329 (2000) 587-596
183. Mueller A., Raptis J., Rice P.J., Kalbfleisch J.H., Stout R.D., Ensley H.E., et al. The influence of glucan polymer structure and solution conformation on binding to (1 → 3)-β-d-glucan receptors in a human monocyte-like cell line. Glycobiology 10 (2000) 339-346
184. Yoon E.J., Yoo S.H., Cha J., and Gyu Lee H. Effect of levan's branching structure on antitumor activity. Int J Biol Macromol 34 (2004) 191-194
185. Rouhier P., Kopp M., Begot V., Bruneteau M., and Fritig B. Structural features of fungal β-d-glucans for the efficient inhibition of the initiation of virus infection on Nicotiana tabacum. Phytochemistry 39 (1995) 57-62
186. Kraus J., Blaschek W., Schutz M., and Franz G. Antitumor activity of cell wall β-1,3/1,6-glucans from Phytophthora species. Planta Med 58 (1992) 39-42
187. Suzuki T., Ohno N., Saito K., and Yadomae T. Activation of the complement system by (1 → 3)-β-d-glucans having different degrees of branching and different ultrastructures. J Pharmacobiodyn 15 (1992) 277-285
188. Saito H., Yoshioka Y., Uehara N., Aketagawa J., Tanaka S., and Shibata Y. Relationship between conformation and biological response for (1 → 3)-β-d-glucans in the activation of coagulation factor G from limulus amebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant. Carbohydr Res 217 (1991) 181-190
189. Yoshioka Y., Uehara N., and Saito H. Conformation-dependent change in antitumor activity of linear and branched (1 → 3)-β-d-glucans on the basis of conformational elucidation by carbon-13 nuclear magnetic resonance spectroscopy. Chem Pharm Bull (Tokyo) 40 (1992) 1221-1226
190. Aketagawa J., Tanaka S., Tamura H., Shibata Y., and Saito H. Activation of limulus coagulation factor G by several (1 → 3)-β-d-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J Biochem (Tokyo) 113 (1993) 683-686
191. Hashimoto T., Ohno N., Adachi Y., and Yadomae T. Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol Med Microbiol 19 (1997) 131-135
192. Ohno N., Miura N.N., Chiba N., Adachi Y., and Yadomae T. Comparison of the immunopharmacological activities of triple and single-helical schizophyllan in mice. Biol Pharm Bull 18 (1995) 1242-1247
193. Tateishi T., Ohno N., Adachi Y., and Yadomae T. Increases in hematopoietic responses caused by β-glucans in mice. Biosci Biotechnol Biochem 61 9 (1997) 1548-1553
194. Tsuzuki A., Tateishi T., Ohno N., Adachi Y., and Yadomae T. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1 → 3)-β-d-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice. Biosci Biotechnol Biochem 63 (1999) 104-110
195. Sheets M.A., Unger B.A., Giggleman Jr. G.F., and Tizard I.R. Studies of the effect of acemannan on retrovirus infections: clinical stabilization of feline leukemia virus-infected cats. Mol Biother 3 (1991) 41-45
196. Naito T., Takeda-Hirokawa N., Kaneko H., Sekigawa I., Matsumoto T., Hashimoto H., et al. Role of curdlan sulfate in the production of β-chemokines and interleukin-16. Med Microbiol Immunol (Berl) 187 (1998) 43-48
197. Gauntt C.J., Wood H.J., McDaniel H.R., and McAnalley B.H. Aloe polymannose enhances anti-coxsackievirus antibody titres in mice. Phytother Res 14 (2000) 261-266
198. Sasaki H., Kobayashi M., Pollard R.B., and Suzuki F. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. Pathobiology 69 (2001) 96-103
199. Jung K., Ha Y., Ha S.K., Han D.U., Kim D.W., Moon W.K., et al. Antiviral effect of Saccharomyces cerevisiae β-glucan to swine influenza virus by increased production of interferon-gamma and nitric oxide. J Vet Med B Infect Dis Vet Public Health 51 (2004) 72-76
200. Yun C.H., Estrada A., Van Kessel A., Gajadhar A.A., Redmond M.J., and Laarveld B. β-(1 → 3, 1 → 4) oat glucan enhances resistance to Eimeria vermiformis infection in immunosuppressed mice. Int J Parasitol 27 (1997) 329-337
201. Hrckova G., and Velebny S. Treatment of Toxocara canis infections in mice with liposome-incorporated benzimidazole carbamates and immunomodulator glucan. J Helminthol 75 (2001) 141-146
202. Hashimoto K., Okawa Y., Suzuki K., Okura Y., Suzuki S., and Suzuki M. Antitumor activity of acidic mannan fraction from Bakers' yeast. J Pharmacobiodyn 6 (1983) 668-676
203. Ogawa Y., Inomata T., Yoshida S., Maeda T., and Seguchi H. Experimental study of the antitumor effect of Z-100 in the treatment of MM46 tumor transplanted in C3H/He mice. 2. Effect of the combination therapy of radiation and long term administration of Z-100. Nippon Gan Chiryo Gakkai Shi 24 (1989) 51-56
204. Peng S.Y., Norman J., Curtin G., Corrier D., McDaniel H.R., and Busbee D. Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, Acemannan. Mol Biother 3 (1991) 79-87
205. Ohnishi M., Kimura S., Yamazaki M., Oshima H., Mizuno D.I., Abe S., et al. Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis. Br J Cancer 69 (1994) 1038-1042
206. Oka H., Emori Y., Sasaki H., Shiraishi Y., Yoshinaga K., and Kurimoto T. Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis. Microbiol Immunol 46 (2002) 343-351
207. Kado H., Yoneta Y., Takeo S., Mitsui M., and Watanabe N. Studies on an enzymatically synthesized antitumor polysaccharide SPR-901. Chem Pharm Bull (Tokyo) 39 (1991) 1078-1079
208. Xiao Z., Trincado C.A., and Murtaugh M.P. β-Glucan enhancement of T cell IFNgamma response in swine. Vet Immunol Immunopathol 102 (2004) 315-320
209. Tsang K.W., Lam C.L., Yan C., Mak J.C., Ooi G.C., Ho J.C., et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 97 (2003) 618-624
210. Taguchi T., Furue H., Kimura T., Kondo T., Hattori T., Itoh I., et al. Results of phase III study of lentinan. Gan To Kagaku Ryoho 12 (1985) 366-378
211. Okamura K., Suzuki M., Chihara T., Fujiwara A., Fukuda T., Goto S., et al. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study. Cancer 58 (1986) 865-872
212. Taguchi T. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer Detect Prev Suppl 1 (1987) 333-349
213. Kosaka A., Kuzuoka M., Yamafuji K., Imaizumi A., Hattori Y., and Yamashita A. Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans. Gan To Kagaku Ryoho 14 (1987) 516-522
214. Mitomi T., et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis Colon Rectum 35 (1992) 123-130
215. Ogoshi K., et al. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Am J Clin Oncol 18 (1995) 216-222
216. Nakano H., et al. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Hepatogastroenterology 46 (1999) 2662-2668
217. Ohwada S., Kawate S., Ikeya T., Yokomori T., Kusaba T., Roppongi T., et al. Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial. Dis Colon Rectum 46 (2003) 1060-1068
218. Ito K., Nakazato H., Koike A., Takagi H., Saji S., Baba S., et al. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int J Colorectal Dis 19 (2004) 157-164
219. Tari K., Satake I., Nakagomi K., Ozawa K., Oowada F., Higashi Y., et al. Effect of lentinan for advanced prostate carcinoma. Hinyokika Kiyo 40 (1994) 119-123
220. Kimura Y., Iijima S., Kato T., Tsujie M., Naoi Y., Hayashi T., et al. Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer pilot study aiming at a randomized trial. Gan To Kagaku Ryoho 30 (2003) 1125-1130
221. Saji S., et al. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Surg Today 29 (1999) 504-510
222. Nishiwaki Y., et al. A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. Gan To Kagaku Ryoho 17 1 (1990) 131-136
223. Torisu M., Hayashi Y., Ishimitsu T., Fujimura T., Iwasaki K., Katano M., et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 31 (1990) 261-268
224. Yoshino S., Tabata T., Hazama S., Iizuka N., Yamamoto K., Hirayama M., et al. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers. Anticancer Res 20 (2000) 4707-4711